Company Filing History:
1 out of 1 
1 out of 8 
1 out of 480 
Years Active: 2019
Title: Innovations of Josep Gregori in Hepatitis C Research
Introduction
Josep Gregori is a notable inventor based in Caldes de Montbui, Spain. He has made significant contributions to the field of medical research, particularly in the detection of human hepatitis C virus (HCV) variants. His innovative work has implications for improving diagnostic methods and enhancing patient care.
Latest Patents
Josep Gregori holds a patent for "Primers and methods for detecting human hepatitis C virus (HCV) variants in an isolated sample." This invention relates to an in vitro method for determining the presence of one or more HCV sequence variants in an isolated sample. The method involves reverse transcription and amplification of HCV RNA molecules using specific sets of primers. These primers allow for the amplification of critical HCV regions, specifically the 5'-UTR-Core and NS5B. The process includes steps for purifying the amplified regions and sequencing the fragments. Additionally, the invention encompasses specific oligonucleotides used as primers and kits that include these oligonucleotides.
Career Highlights
Throughout his career, Josep Gregori has worked with esteemed institutions such as Fundació Hospital Universitari Vall D'Hebron - Institut de Recerca and Centro de Investigación Biomédica en Red. His work in these organizations has contributed to advancements in biomedical research and diagnostics.
Collaborations
Josep Gregori has collaborated with notable professionals in his field, including Josep Quer and Francisco Rodríguez. These collaborations have furthered research efforts and enhanced the development of innovative diagnostic methods.
Conclusion
Josep Gregori's contributions to the detection of hepatitis C virus variants highlight his role as an influential inventor in the medical research community. His patented methods and collaborations reflect a commitment to advancing healthcare through innovation.